Company Filing History:
1 out of 99 
1 out of 185 
Years Active: 2011-2017
Title: Allister Fraser: Innovator in Lipid Compounds and Serine Hydrolase Inhibitors
Introduction
Allister Fraser is a notable inventor based in Encinitas, California. He has made significant contributions to the field of lipid compounds and serine hydrolase inhibitors. With a total of 2 patents, Fraser's work has implications in various medical applications.
Latest Patents
Fraser's latest patents include "Amine cationic lipids and uses thereof." This invention relates to lipid compounds that feature a class of cationic lipids with an amine moiety. These lipid compounds are particularly useful for the in vivo or in vitro delivery of agents, such as polyanionic payloads or RNAi agents. Another significant patent is for "Serine hydrolase inhibitors," which provides benzoxazinone compounds and compositions that inhibit the action of serine hydrolase, including neutrophil elastase. These compounds are valuable in the prevention and treatment of serine hydrolase-mediated diseases.
Career Highlights
Fraser has worked with prominent companies in the pharmaceutical industry, including Dicerna Pharmaceuticals, Inc. and Kyorin Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop innovative solutions in drug delivery and disease treatment.
Collaborations
Fraser has collaborated with notable professionals in his field, including Bob Dale Brown and Sujit Basu. These partnerships have contributed to the advancement of his research and inventions.
Conclusion
Allister Fraser's contributions to the fields of lipid compounds and serine hydrolase inhibitors highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to advancing science and technology for better health outcomes.